Supriya Lifescience Limited (NSE:SUPRIYA) — Stock Price

Rs922.85 INR
▼ -0.06% today

Supriya Lifescience Limited (NSE:SUPRIYA) is currently trading at Rs922.85 INR, down 0.06% today. Over the past 52 weeks, shares have ranged between Rs553.35 and Rs1052.50. This page tracks Supriya Lifescience Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Supriya Lifescience Limited market capitalisation.

Supriya Lifescience Limited (SUPRIYA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Supriya Lifescience Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Supriya Lifescience Limited Income Statement — Revenue, Profit & Earnings by Year

Supriya Lifescience Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs6.96 Billion Rs5.70 Billion Rs4.51 Billion Rs5.19 Billion Rs3.85 Billion
Cost of Revenue Rs3.12 Billion Rs3.61 Billion Rs1.81 Billion Rs2.30 Billion Rs1.51 Billion
Gross Profit Rs3.84 Billion Rs2.80 Billion Rs2.80 Billion Rs2.89 Billion Rs2.34 Billion
Research & Development — Rs66.88 Million Rs54.04 Million Rs16.62 Million Rs6.61 Million
SG&A Rs805.19 Million Rs231.87 Million Rs192.26 Million Rs137.32 Million Rs105.17 Million
Total Operating Expenses Rs1.44 Billion Rs791.09 Million Rs784.25 Million Rs655.81 Million Rs501.41 Million
Operating Income Rs2.40 Billion Rs1.57 Billion Rs1.15 Billion Rs2.02 Billion Rs1.64 Billion
EBITDA Rs2.71 Billion Rs1.84 Billion Rs1.37 Billion Rs2.22 Billion Rs1.77 Billion
EBIT Rs2.50 Billion Rs1.68 Billion Rs1.25 Billion Rs2.11 Billion Rs1.70 Billion
Interest Expense Rs16.86 Million Rs20.75 Million Rs30.84 Million Rs41.98 Million Rs40.80 Million
Income Before Tax Rs2.48 Billion Rs1.66 Billion Rs1.23 Billion Rs2.07 Billion Rs1.67 Billion
Income Tax Expense Rs605.23 Million Rs465.76 Million Rs336.30 Million Rs554.35 Million Rs435.65 Million
Net Income Rs1.88 Billion Rs1.19 Billion Rs898.57 Million Rs1.52 Billion Rs1.24 Billion

Supriya Lifescience Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Supriya Lifescience Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs11.12 Billion Rs9.21 Billion Rs8.20 Billion Rs7.35 Billion Rs4.46 Billion
Total Current Assets Rs4.37 Billion Rs3.98 Billion Rs4.65 Billion Rs4.98 Billion Rs2.66 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs604.66 Million Rs350.04 Million Rs802.11 Million Rs591.55 Million Rs429.28 Million
Net Receivables Rs1.35 Billion Rs1.17 Billion Rs916.16 Million Rs1.22 Billion Rs941.63 Million
Inventory Rs1.18 Billion Rs852.49 Million Rs1.16 Billion Rs923.11 Million Rs724.80 Million
Property, Plant & Equipment — — — Rs2.32 Billion Rs1.77 Billion
Goodwill — Rs1.00 Rs10.00K — —
Total Liabilities Rs1.16 Billion Rs1.06 Billion Rs1.21 Billion Rs1.19 Billion Rs1.77 Billion
Total Current Liabilities Rs821.62 Million Rs768.94 Million Rs957.80 Million Rs996.99 Million Rs1.46 Billion
Long-term Debt Rs0.00 Rs0.00 Rs0.00 Rs0.00 Rs0.00
Net Debt Rs-737.74 Million Rs-626.80 Million Rs-627.83 Million Rs-1.38 Billion Rs411.22 Million
Total Stockholder Equity Rs9.97 Billion Rs8.15 Billion Rs6.99 Billion Rs6.16 Billion Rs2.69 Billion
Retained Earnings Rs7.82 Billion Rs6.00 Billion Rs4.86 Billion Rs4.01 Billion Rs2.54 Billion

Supriya Lifescience Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Supriya Lifescience Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs1.73 Billion Rs1.13 Billion Rs661.87 Million Rs488.01 Million Rs799.30 Million
Capital Expenditures Rs1.62 Billion Rs1.46 Billion Rs1.08 Billion Rs599.04 Million Rs482.41 Million
Free Cash Flow Rs101.89 Million Rs-323.48 Million Rs-422.13 Million Rs-111.03 Million Rs316.89 Million
Investing Cash Flow Rs-1.62 Billion Rs-1.74 Billion Rs-1.33 Billion Rs-598.22 Million Rs-468.01 Million
Financing Cash Flow Rs-65.47 Million Rs-223.59 Million Rs-33.68 Million Rs1.50 Billion Rs-149.31 Million
Dividends Paid Rs64.39 Million Rs48.29 Million Rs48.29 Million Rs43.91 Million Rs39.56 Million
Stock-Based Compensation — — — — —
Depreciation Rs204.44 Million Rs158.11 Million Rs118.06 Million Rs101.18 Million Rs66.78 Million
Change in Cash Rs41.98 Million Rs-826.26 Million Rs-703.26 Million Rs1.39 Billion Rs175.88 Million

Supriya Lifescience Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Supriya Lifescience Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 25, 2026 — — —
Feb 09, 2026 6.17 6.90 -10.58%
Oct 28, 2025 — — —
Aug 08, 2025 — — —
May 28, 2024 4.59 — —
Feb 07, 2024 3.70 — —
Nov 07, 2023 2.97 — —
Mar 01, 2023 0.00 0.00 —